Varaico: Literature-Extracted Genetic Variants

Gene:PFN1
Variant:p.C71G
Back to variants list

PFN1

NM_005022.4:p.C71G

Associated Papers

A Missense Mutation in Close Proximity of ALS-linked PFN1 Mutations Causes Only Early-onset Paget Disease of Bone.

Weng R et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Inborn errors of canonical autophagy in neurodegenerative diseases.

Freisem D et al.

Human Molecular Genetics, 2025

Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review.

Yuan L et al.

Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2025

Targeting Amyotrophic Lateral Sclerosis with Gene Therapy: From Silencing Genes to Enhancing Neuroprotection.

Verdés S et al.

Human Gene Therapy, 2025

Nuclear Profilin-1 for DNA Damage Repair Is Involved in Phagocytic Impairment of Senescent Microglia.

Rim C et al.

Glia, 2025

Abnormal regulation of membrane-less organelles contributes to profilin1-associated ALS.

Ma G et al.

The Journal of Biological Chemistry, 2025

Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model.

Hawley ZCE et al.

Acta Neuropathologica Communications, 2025

Aggregates associated with amyotrophic lateral sclerosis sequester the actin-binding protein profilin 2.

Kubinski S et al.

Human Molecular Genetics, 2025

Using ALS to understand profilin 1's diverse roles in cellular physiology.

Lindamood HL et al.

Cytoskeleton (hoboken, N.j.), 2025

The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Beckers J et al.

Autophagy Reports, 2025

A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.

Arreola-Aldape CA et al.

Frontiers in Neuroscience, 2025

40589786 (PubMed )
Supplement: Table_4.xlsx › ClinVar_filtered_variants

Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.

Nikel LM et al.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology, 2024

Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia.

Funes S et al.

Nature Communications, 2024

Protein Citrullination in Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.

Yusuf IO et al.

Journal of Experimental Neurology, 2024

Proximity Proteomics Revealed Aberrant mRNA Splicing Elicited by ALS-Linked Profilin-1 Mutants.

Wei S et al.

Analytical Chemistry, 2023

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.

Bagyinszky E et al.

Cells, 2023

Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia.

Funes S et al.

Biorxiv : the Preprint Server for Biology, 2023

Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis.

Corcia P et al.

European Journal of Neurology, 2023

The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682YENPTY687 motif.

Matrone C

Computational and Structural Biotechnology Journal, 2023

Novel variant c.92T > G (p.Val31Gly) in the PFN1 gene (ALS18) responsible for a specific phenotype in a large Bulgarian amyotrophic lateral sclerosis pedigree.

Angelov T et al.

Frontiers in Neurology, 2023

Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis.

Zhou W et al.

Frontiers in Neuroscience, 2023

Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.

McCann EP et al.

Journal of Neuromuscular Diseases, 2023

37638449 (PubMed )
Supplement: jnd-10-jnd230148-s001.xlsx › variant_list

Protein citrullination marks myelin protein aggregation and disease progression in mouse ALS models.

Yusuf IO et al.

Acta Neuropathologica Communications, 2022

Multiple roles for the cytoskeleton in ALS.

Liu X et al.

Experimental Neurology, 2022

The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis.

Teyssou E et al.

International Journal of Molecular Sciences, 2022

The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Davidson JM et al.

Neurobiology of Disease, 2022

Biochemical characterization of actin assembly mechanisms with ALS-associated profilin variants.

Liu X et al.

European Journal of Cell Biology, 2022

Modelling amyotrophic lateral sclerosis in rodents.

Todd TW et al.

Nature Reviews. Neuroscience, 2022

Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Bonifacino T et al.

International Journal of Molecular Sciences, 2021

Novel reporters of mitochondria-associated membranes (MAM), MAMtrackers, demonstrate MAM disruption as a common pathological feature in amyotrophic lateral sclerosis.

Sakai S et al.

Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2021

ALS-linked PFN1 variants exhibit loss and gain of functions in the context of formin-induced actin polymerization.

Schmidt EJ et al.

Proceedings of the National Academy of Sciences of the United States of America, 2021

1–50 of 104 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."